Lupin Pharmaceuticals Inc. — Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02) bottles, Rx only, Manufactured for Lupin P
⚠️ CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- October 23, 2024
Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
What's affected?
- Product
- Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India
- Brand
- RAMIPRIL
- UPC
- 0368180591092
- Lot code
- G327086
Additional details
a) NDC 68180-591-09; Lots G327086, exp. date 30-Sep-25 GA01065, exp. date 31-Dec-25, b) NDC 68180-591-01 Lots G325033, G324987, exp. date 31-Jul-25, G325110, GA00956, GA01066, GA01126, exp. date 31-Dec-25, GA03299, GA03288, GA03287, exp. date 31-Mar-26 c) NDC 68180-591-02 Lot GA05919, exp. date 31-Jul-26 G327131, exp. date 30-Sep-25
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 357,414 bottles.
Get Health recall alerts
Delivered to your inbox. Free. No account required.